SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (18979)2/21/1999 3:30:00 PM
From: VLAD  Read Replies (1) of 23519
 
Read this:

citizen.org

Scary stuff!

We have 2 completely opposite view points here.

1)The big Kahuna type that is only concerned about his investment portfolio in big pharma drugs and gets excited every time another pill is approved to be pushed to the American public. I believe Celebrex an over priced anti-inflammatory that is attempting to claim (falsely so) that it doesn't have any GI effects of decreased stomach mucus production as does all other NSAID is the latest scam that the Kahuna is peeing in his pants over.

2)The Public Citizen's Group which is an organization founded to protect the public interests over big pharma's profit interest and is supported by over 150,000 American citizen's nation wide. There is NO financial motivation in the PC's decisions. They just don't want to see ineffective or dangerous drugs sold to the American public for the sake of big pharma profit over patient safety concerns.

Kahuna,

I am NOT anti-big pharm nor I am I an anti-precription drug advocate but the way the American big pharma companies compete amongst each other as a race against the clock to see who can come out with the next drug to get a larger piece of a particular drug group pie IMHO places a priority of big pharma profitability over consumer safety. You know this industry all too well to deny this game that constantly takes place in this industry. One way a big pharma company can get an "edge" over the competition is to contribute large amounts of money toward political campaigns and towards Washington lobbyists to promote their agendas. Pfizer has been at the forefront in buying the political clout needed to get its way in circumstances where a small company like Vivus wouldn't stand a chance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext